2018 Speaking Faculty


Biosimilars Market Access & Commercialization Summit

Amal Agarwal
Amal Agarwal
Medical Director
Humana


John Alter
John Alter
Vice President, Patient and Health Impact
Pfizer Essential Health Business Unit


Charlie Barr
Charlie Barr
Chief Science Officer
BBCIC Research Consortium Academy of Managed Care Pharmacy (AMCP)


Ana Cespedes
Ana Cespedes
Senior Vice President, Global Head, Market Access and Pricing
Merck


Jim Clement
Jim Clement
Executive Director, Cost of Care & Supply Chain Strategy
Aetna


Rakesh Dixit
Rakesh Dixit, Ph.D., DABT
Vice President R&D, Global Head, Biologics Safety Assessment
Medimmune


Joseph P. Fuhr Jr.
Joseph P. Fuhr Jr., PhD
Professor Emeritus of Economics Widener University and Adjunct Faculty
College of Population Health Thomas Jefferson University


John Garcia
John Garcia
Global Commercial Excellence Lead
Alnylam


Stanislav Glezer
Stanislav Glezer, MD MBA
Chief Medical Officer
Adocia


Robert Goldberg
Robert Goldberg, PhD
President and Co-Founder
Center For Medicine in Public Interest


Chris Guinther
Chris Guinther
System Director, Managed Care Pharmacy Services
Mercy Health


Ann Hartry
Ann Hartry
VP, HEOR
Lundbeck


Photo Not Available
Chrys Kokino
Head Global Biologic Commercial
Mylan


Brian Martinson
Brian Martinson
Specialty Pharmacy Leader
Lediant Biosciences, Inc.


Ed McAdam
Ed McAdam
Executive Director, Pricing and Contracting
Intarcia Therapeutics, Inc.


Lindsay McKenna
Lindsay McKenna
Associate Principal
McKinsey & Company


John Josef Molenda
John Josef Molenda, PhD
Partner, Steptoe & Johnson LLPM
Co-Chair, Healthcare & Life Sciences Industry Practice


Morgan Molloy
Morgan Molloy
Chief Commercial Officer
Enzyvant Therapeutics


Jose Ricardo Perez
Jose Ricardo Perez, US CDMA
Executive Medical Director
Exelixis Inc


Edmund Pezalla
Edmund Pezalla
Former Vice President, National Medical Director, Pharmaceutical Policy and Strategy
Aetna


Robert Popovian
Robert Popovian
Vice President, US Government Relations
Pfizer


Ashish Sagrolikar
Ashish Sagrolikar
VP, Commercial Transformation
GSK


Grace-Marie Turner
Grace-Marie Turner
President
Galen Institute


Reg Waldeck
Reg Waldeck
Market Access Leader
Bayer


Amber Walker
Amber Walker
Director, Specialty Pharmacy Development-Rare and Orphan
Walgreens


Gillian Woollett
Gillian Woollett
Senior Vice President
Avalere Health


Gergana Zlateva
Gergana Zlateva
Patient & Health Impact, Oncology Market Access Lead
Pfizer


Burt Zweigenhaft
Burt Zweigenhaft
President
National Association of Specialty Pharmacy


5th Annual Oncology Market Access & Commercialization Summit Speakers

Amal Agarwal
Amal Agarwal
Medical Director
Humana


John Alter
John Alter
Vice President, Patient and Health Impact
Pfizer Essential Health Business Unit


Alan Balch
Alan Balch, PhD
CEO
Patient Advocate Foundation


Robert W. Carlson
Robert W. Carlson, MD
Chief Executive Officer
NCCN®


Ana Cespedes
Ana Cespedes
Senior Vice President, Global Head, Market Access and Pricing
Merck


Adrian Chabrin
Adrian Chabrin, PhD
Director, Global Payer Insights & Access
Pfizer


Photo Not Available
Cindy Chmielewski
Patient Advocate
Patient Power


Jim Clement
Jim Clement
Executive Director, Cost of Care & Supply Chain Strategy
Aetna


Stanislav Glezer
Stanislav Glezer, MD MBA
Chief Medical Officer
Adocia


Robert Goldberg
Robert Goldberg, PhD
President and Co-Founder
Center For Medicine in Public Interest


Chris Guinther
Chris Guinther
System Director, Managed Care Pharmacy Services
Mercy Health


Ann Hartry
Ann Hartry
VP, HEOR
Lundbeck


Mridula Iyer
Mridula Iyer, Ph.D.
General Manager, Precision Medicine
Quest Diagnostics


Ed McAdam
Ed McAdam
Executive Director, Pricing and Contracting
Intarcia Therapeutics, Inc.


Lindsay McKenna
Lindsay McKenna
Associate Principal
McKinsey & Company


Morgan Molloy
Morgan Molloy
Chief Commercial Officer
Enzyvant Therapeutics


Bob Orzechowski
Bob Orzechowski
CEO
Lancaster Cancer Center


Edmund Pezalla
Edmund Pezalla
Former Vice President, National Medical Director, Pharmaceutical Policy and Strategy
Aetna


Osama Rahma
Osama Rahma, MD
Assistant Professor of Medicine
Center For Immuno-Oncology |Gastrointestinal Cancer Center
Dana-Farber Cancer Institute| Harvard Medical School


Ashish Sagrolikar
Ashish Sagrolikar
VP, Commercial Transformation
GSK


Sophie Shen
Sophie Shen, PhD
Director Healthcare Quality
Johnson & Johnson


Scott Harold Shortenhaus
Scott Harold Shortenhaus
Director Lilly Oncology, US, PACE, Policy and Advocacy
Eli Lilly


Stephanie Trunk
Stephanie Trunk
Partner
Arent Fox LLP


Grace-Marie Turner
Grace-Marie Turner
President
Galen Institute


Reg Waldeck
Reg Waldeck
Market Access Leader
Bayer


Gergana Zlateva
Gergana Zlateva
Patient & Health Impact, Oncology Market Access Lead
Pfizer


Burt Zweigenhaft
Burt Zweigenhaft
President
National Association of Specialty Pharmacy


Cell & Gene Therapy Commercialization Summit

Amal Agarwal
Amal Agarwal
Medical Director
Humana


John Alter
John Alter
Vice President, Patient and Health Impact
Pfizer Essential Health Business Unit


Ana Cespedes
Ana Cespedes
Senior Vice President, Global Head, Market Access and Pricing
Merck


Stephen Chang
Stephen Chang
Senior Vice President for Strategic Research Initiatives
NY Stem Cell Foundation


Jim Clement
Jim Clement
Executive Director, Cost of Care & Supply Chain Strategy
Aetna


Benjamin Fryer
Benjamin Fryer, PhD
Team Leader, Processing/Manufacturing, Heart Regeneration Program
University of Washington School of Medicine


Stanislav Glezer
Stanislav Glezer, MD MBA
Chief Medical Officer
Adocia


Robert Goldberg
Robert Goldberg, PhD
President and Co-Founder
Center For Medicine in Public Interest


Chris Guinther
Chris Guinther
System Director, Managed Care Pharmacy Services
Mercy Health


Ann Hartry
Ann Hartry
VP, HEOR
Lundbeck


Photo Not Available
Doug Jolly
Executive Vice President, Research and Pharmaceutical Development
Tocagen


Vikas Kundra
Vikas Kundra, MD, PhD
Director Molecular Imaging, Department of Radiology, M.D.
Anderson Cancer Center


Ed McAdam
Ed McAdam
Executive Director, Pricing and Contracting
Intarcia Therapeutics, Inc.


Lindsay McKenna
Lindsay McKenna
Associate Principal
McKinsey & Company


Morgan Molloy
Morgan Molloy
Chief Commercial Officer
Enzyvant Therapeutics


C. David Pauza
C. David Pauza, PhD
Chief Science Officer
American Gene Technologies


Jose Ricardo Perez
Jose Ricardo Perez, US CDMA
Executive Medical Director
Exelixis Inc


Edmund Pezalla
Edmund Pezalla
Former Vice President, National Medical Director, Pharmaceutical Policy and Strategy
Aetna


Ashish Sagrolikar
Ashish Sagrolikar
VP, Commercial Transformation
GSK


Lincoln Tsang
Lincoln Tsang, PhD
Partner, Life Science Practice
Arnold & Porter Kaye Scholer LLP


Grace-Marie Turner
Grace-Marie Turner
President
Galen Institute


Satish Vullari
Satish Vullari
Director, US Rare Disease Patient Access
Pfizer


Reg Waldeck
Reg Waldeck
Market Access Leader
Bayer


Gergana Zlateva
Gergana Zlateva
Patient & Health Impact, Oncology Market Access Lead
Pfizer


Burt Zweigenhaft
Burt Zweigenhaft
President
National Association of Specialty Pharmacy